---
title: "Fem Care Pharma Ltd(merged) (524608) — Share Price, Financials & Analysis"
symbol: "524608"
company: "Fem Care Pharma Ltd(merged)"
canonical: "https://tapetide.com/stocks/524608"
isin: "INE954D01014"
bse_code: "524608"
generated_at: "2026-10-13T10:59:44.569Z"
---

# Fem Care Pharma Ltd(merged) (524608)

Canonical page: https://tapetide.com/stocks/524608

## Company

- **BSE Code:** 524608
- **ISIN:** INE954D01014
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** femcareworld.com

## Latest Price

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 42.3%

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 12% | 22% |
| revenue growth | 15% | 15% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 47.17 | 17.22 | 28.15 | 30.04 | 23.09 | 16.99 | 13.39 | 16.19 | 0.69 | 0 | 0 | 0 |
| Expenses | 32.7 | 31.06 | 24.72 | 27.72 | 22.53 | 15.34 | 10.54 | 12.99 | 0.94 | 0.22 | 0.26 | 0.19 |
| Operating Profit | 14.47 | -13.84 | 3.43 | 2.32 | 0.56 | 1.65 | 2.85 | 3.2 | -0.25 | -0.22 | -0.26 | -0.19 |
| OPM % | 30.68 | -80.37 | 12.18 | 7.72 | 2.43 | 9.71 | 21.28 | 19.77 | -36.23 | — | — | — |
| Other Income | 0 | 0 | 5.13 | 0 | 0 | -0.92 | 0 | 0.04 | 0.05 | 0 | 0 | 0 |
| Interest | 0.15 | 0.15 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.13 | 0.13 | 0.14 | 0.13 | 0.12 | 0.1 | 0.07 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 14.19 | -14.12 | 8.38 | 2.19 | 0.44 | 0.63 | 2.78 | 3.24 | -0.2 | -0.22 | -0.26 | -0.19 |
| Tax % | 25.23 | -24.43 | 25.3 | 26.48 | 27.27 | 119.05 | 25.9 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 10.61 | -10.67 | 6.25 | 1.62 | 0.32 | -0.12 | 2.06 | 3.24 | -0.2 | -0.22 | -0.26 | -0.19 |
| EPS in Rs | 0.97 | -0.98 | 0.57 | 0.15 | 0.03 | -0.01 | 0.13 | 0.2 | -0.01 | -0.01 | -0.02 | -0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 |
| --- | --- | --- | --- | --- |
| Sales | 70 | 81 | 94 | 107 |
| Expenses | 59 | 65 | 80 | 92 |
| Operating Profit | 11 | 16 | 14 | 16 |
| OPM % | 16 | 20 | 15 | 15 |
| Other Income | 1 | 1 | -2 | 0 |
| Interest | 0 | 0 | 1 | 1 |
| Depreciation | 1 | 2 | 2 | 3 |
| Profit before tax | 12 | 16 | 9 | 12 |
| Tax % | 40 | 27 | 13 | 14 |
| Net Profit | 7 | 11 | 8 | 11 |
| EPS in Rs | — | — | — | 30.43 |
| Dividend Payout % | 27 | 27 | 26 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 |
| --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 4 |
| Reserves | 13 | 19 | 25 | 36 |
| Borrowings | 3 | 3 | 18 | 19 |
| Other Liabilities | 25 | 33 | 20 | 20 |
| Total Liabilities | 44 | 58 | 65 | 78 |
| Fixed Assets | 11 | 21 | 34 | 33 |
| CWIP | 10 | 5 | 1 | 0 |
| Investments | 1 | 0 | 2 | 9 |
| Other Assets | 22 | 33 | 29 | 35 |
| Total Assets | 44 | 58 | 65 | 78 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 10 | 6 | 12 | 18 |
| Cash from Investing Activity | -7 | -5 | -17 | -10 |
| Cash from Financing Activity | -1 | -2 | 9 | -6 |
| Net Cash Flow | 1 | -1 | 4 | 2 |
| Free Cash Flow | 2 | -1 | 0 | 15 |
| CFO/OP | 122 | 62 | 99 | 123 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 |
| --- | --- | --- | --- | --- |
| Debtor Days | 21 | 17 | 19 | 23 |
| Inventory Days | 71 | 162 | 107 | 97 |
| Days Payable | 122 | 100 | 99 | 84 |
| Cash Conversion Cycle | -30 | 78 | 27 | 36 |
| Working Capital Days | -31 | 3 | 18 | 27 |
| ROCE % | — | 68 | 35 | 29 |

## Shareholding Pattern

### annual

| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 64.79% | 64.79% | 64.79% | 49.26% | 36.66% | 9.41% | 9.41% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0.03% | 0% |
| Public | 35.21% | 35.21% | 35.21% | 50.74% | 63.34% | 90.56% | 90.59% |
| No. of Shareholders | 215 | 214 | 171 | 191 | 13289 | 53389 | 72429 |

### Quarterly

| Category | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 43.75% | 36.66% | 36.66% | 36.66% | 48.77% | 34.15% | 34.15% | 9.41% | 9.41% | 9.41% | 9.41% | 9.41% |
| FIIs | 0% | 0% | 0.04% | 0% | 0% | 0% | 0% | 0.03% | 0% | 0% | 0% | 0% |
| Public | 56.26% | 63.34% | 63.29% | 63.34% | 51.23% | 65.85% | 65.85% | 90.56% | 90.59% | 90.59% | 90.59% | 90.59% |
| No. of Shareholders | 1921 | 6126 | 11824 | 13289 | 14087 | 21462 | 29496 | 53389 | 57201 | 59573 | 71918 | 72429 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 6 / 7 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 217.62 | Buy |
| EMA (10) | 218.01 | Buy |
| SMA (20) | 220.19 | Sell |
| EMA (20) | 219.03 | Sell |
| SMA (50) | 216.61 | Buy |
| EMA (50) | 218.2 | Sell |
| SMA (100) | 218.46 | Sell |
| EMA (100) | 212.69 | Buy |
| SMA (200) | 193.97 | Buy |
| EMA (200) | 206.13 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 48.85 | Neutral |
| MACD (12,26,9) | -0.85 | Sell |
| Stochastic (14,3,3) | 50.49 | Neutral |
| ADX (14) | 16.01 | Neutral |
| Williams %R (14) | -46.19 | Neutral |
| ATR (14) | 11.71 | High Volatility |
| ROC (12) | -2.37 | Sell |
| Stoch RSI (14) | 61.24 | Neutral |
| UO (7,14,28) | 52.07 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-02-14 | [Integrated Filing- Financial](https://nsearchives.nseindia.com/corporate/DSML_14022026190347_Integrated_Filing__Financial_docx.pdf) |
| 2026-02-14 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/DSML_14022026185327_outcome_of_BM_docx.pdf) |
| 2026-02-14 | [General Updates](https://nsearchives.nseindia.com/corporate/DSML_14022026190644_Results.pdf) |
| 2025-12-10 | [Clarification - Financial Results](https://www.nseindia.com/get-quotes/equity?symbol=DIL) |
| 2025-11-15 | [Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/DSML_15112025211517_BM.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2024 | [Financial Year 2024](https://archives.nseindia.com/annual_reports/AR_25975_DIL_2023_2024_06092024153859.pdf) |
| 2023 | [Financial Year 2023](https://archives.nseindia.com/annual_reports/AR_23875_DIL_2022_2023_08092023195402_09082023200021.zip) |
| 2022 | [Financial Year 2022](https://archives.nseindia.com/annual_reports/AR_21376_DIL_2021_2022_05092022175855_09052022180003.zip) |
| 2021 | [Financial Year 2021](https://archives.nseindia.com/annual_reports/SME_AR_19778_DSML_2020_2021_09092021221653_09092021230005.zip) |
| 2020 | [Financial Year 2020](https://archives.nseindia.com/annual_reports/SME_AR_16769_DSML_2019_2020_18082020193506_18082020200003.zip) |
| 2019 | [Financial Year 2019](https://archives.nseindia.com/annual_reports/SME_AR_16079_DSML_2018_2019_27092019144852_27092019150014.zip) |
| 2018 | [Financial Year 2018](https://archives.nseindia.com/annual_reports/SME_AR_14291_DSML_2017_2018_15102018124638.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:44.569Z.